HEADER NUCLEAR PROTEIN/AGONIST 13-JUL-18 6E3E TITLE STRUCTURE OF RORGT IN COMPLEX WITH A NOVEL INVERSE AGONIST. COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 5 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 6 ORPHAN RECEPTOR-GAMMA; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR HORMONE RECEPTOR, INVERSE AGONIST, NUCLEAR PROTEIN-AGONIST KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.J.SKENE,I.HOFFMAN REVDAT 3 13-MAR-24 6E3E 1 REMARK REVDAT 2 29-JUL-20 6E3E 1 JRNL REVDAT 1 17-JUL-19 6E3E 0 JRNL AUTH T.YUKAWA,Y.NARA,M.KONO,A.SATO,T.ODA,T.TAKAGI,T.SATO,Y.BANNO, JRNL AUTH 2 N.TAYA,T.IMADA,Z.SHIOKAWA,N.NEGORO,T.KAWAMOTO,R.KOYAMA, JRNL AUTH 3 N.UCHIYAMA,R.SKENE,I.HOFFMAN,C.H.CHEN,B.SANG,G.SNELL, JRNL AUTH 4 R.KATSUYAMA,S.YAMAMOTO,J.SHIRAI JRNL TITL DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF RETINOIC JRNL TITL 2 ACID-RELATED ORPHAN RECEPTOR GAMMA T (ROR GAMMA T) AGONIST JRNL TITL 3 STRUCTURE-BASED FUNCTIONALITY SWITCHING APPROACH FROM IN JRNL TITL 4 HOUSE ROR GAMMA T INVERSE AGONIST TO ROR GAMMA T AGONIST. JRNL REF J.MED.CHEM. V. 62 1167 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 30652849 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01181 REMARK 2 REMARK 2 RESOLUTION. 2.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 23909 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1288 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.47 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1768 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.68 REMARK 3 BIN R VALUE (WORKING SET) : 0.2480 REMARK 3 BIN FREE R VALUE SET COUNT : 97 REMARK 3 BIN FREE R VALUE : 0.3020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3532 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 77.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03000 REMARK 3 B22 (A**2) : -0.03000 REMARK 3 B33 (A**2) : 0.10000 REMARK 3 B12 (A**2) : -0.02000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.281 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.213 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.165 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.381 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.967 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.954 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3698 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3506 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4984 ; 1.431 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8032 ; 0.949 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 432 ; 4.791 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 180 ;29.878 ;23.111 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 676 ;16.161 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;17.423 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 540 ; 0.274 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4106 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 894 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 265 A 481 REMARK 3 RESIDUE RANGE : A 501 A 503 REMARK 3 ORIGIN FOR THE GROUP (A): -19.058 -32.373 -2.695 REMARK 3 T TENSOR REMARK 3 T11: 0.0374 T22: 0.0792 REMARK 3 T33: 0.0359 T12: -0.0284 REMARK 3 T13: 0.0110 T23: -0.0329 REMARK 3 L TENSOR REMARK 3 L11: 4.2458 L22: 1.6470 REMARK 3 L33: 2.0479 L12: -0.1336 REMARK 3 L13: 2.1414 L23: 0.7224 REMARK 3 S TENSOR REMARK 3 S11: -0.0866 S12: -0.0148 S13: 0.0970 REMARK 3 S21: 0.0048 S22: -0.1335 S23: 0.1798 REMARK 3 S31: -0.0010 S32: -0.1849 S33: 0.2201 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 265 B 481 REMARK 3 RESIDUE RANGE : B 501 B 503 REMARK 3 ORIGIN FOR THE GROUP (A): -22.486 -30.221 31.652 REMARK 3 T TENSOR REMARK 3 T11: 0.0782 T22: 0.1536 REMARK 3 T33: 0.0273 T12: -0.0017 REMARK 3 T13: -0.0243 T23: 0.0348 REMARK 3 L TENSOR REMARK 3 L11: 1.4272 L22: 4.2241 REMARK 3 L33: 1.6883 L12: -1.5776 REMARK 3 L13: 0.7210 L23: -2.1814 REMARK 3 S TENSOR REMARK 3 S11: -0.0177 S12: 0.0823 S13: 0.0604 REMARK 3 S21: -0.1918 S22: -0.0738 S23: -0.1442 REMARK 3 S31: 0.0674 S32: -0.0279 S33: 0.0915 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 6E3E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUL-18. REMARK 100 THE DEPOSITION ID IS D_1000235651. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25214 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.470 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 9.400 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.47 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.51 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 9.60 REMARK 200 R MERGE FOR SHELL (I) : 0.95900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2%MPD, 1.2M NAFORMATE, 0.1M HEPES 7.5, REMARK 280 PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.76000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 83.52000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 62.64000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 104.40000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 20.88000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 286 -62.70 76.39 REMARK 500 GLU A 435 55.01 -95.36 REMARK 500 GLN B 286 -61.08 73.70 REMARK 500 CYS B 393 56.48 -141.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HQ7 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HQ7 B 503 DBREF 6E3E A 265 481 UNP P51449 RORG_HUMAN 265 481 DBREF 6E3E B 265 481 UNP P51449 RORG_HUMAN 265 481 SEQRES 1 A 217 ALA SER LEU THR GLU ILE GLU HIS LEU VAL GLN SER VAL SEQRES 2 A 217 CYS LYS SER TYR ARG GLU THR CYS GLN LEU ARG LEU GLU SEQRES 3 A 217 ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SER ARG GLU SEQRES 4 A 217 GLU VAL THR GLY TYR GLN ARG LYS SER MET TRP GLU MET SEQRES 5 A 217 TRP GLU ARG CYS ALA HIS HIS LEU THR GLU ALA ILE GLN SEQRES 6 A 217 TYR VAL VAL GLU PHE ALA LYS ARG LEU SER GLY PHE MET SEQRES 7 A 217 GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU LEU LYS ALA SEQRES 8 A 217 GLY ALA MET GLU VAL VAL LEU VAL ARG MET CYS ARG ALA SEQRES 9 A 217 TYR ASN ALA ASP ASN ARG THR VAL PHE PHE GLU GLY LYS SEQRES 10 A 217 TYR GLY GLY MET GLU LEU PHE ARG ALA LEU GLY CYS SER SEQRES 11 A 217 GLU LEU ILE SER SER ILE PHE ASP PHE SER HIS SER LEU SEQRES 12 A 217 SER ALA LEU HIS PHE SER GLU ASP GLU ILE ALA LEU TYR SEQRES 13 A 217 THR ALA LEU VAL LEU ILE ASN ALA HIS ARG PRO GLY LEU SEQRES 14 A 217 GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN TYR ASN LEU SEQRES 15 A 217 GLU LEU ALA PHE HIS HIS HIS LEU CYS LYS THR HIS ARG SEQRES 16 A 217 GLN SER ILE LEU ALA LYS LEU PRO PRO LYS GLY LYS LEU SEQRES 17 A 217 ARG SER LEU CYS SER GLN HIS VAL GLU SEQRES 1 B 217 ALA SER LEU THR GLU ILE GLU HIS LEU VAL GLN SER VAL SEQRES 2 B 217 CYS LYS SER TYR ARG GLU THR CYS GLN LEU ARG LEU GLU SEQRES 3 B 217 ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SER ARG GLU SEQRES 4 B 217 GLU VAL THR GLY TYR GLN ARG LYS SER MET TRP GLU MET SEQRES 5 B 217 TRP GLU ARG CYS ALA HIS HIS LEU THR GLU ALA ILE GLN SEQRES 6 B 217 TYR VAL VAL GLU PHE ALA LYS ARG LEU SER GLY PHE MET SEQRES 7 B 217 GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU LEU LYS ALA SEQRES 8 B 217 GLY ALA MET GLU VAL VAL LEU VAL ARG MET CYS ARG ALA SEQRES 9 B 217 TYR ASN ALA ASP ASN ARG THR VAL PHE PHE GLU GLY LYS SEQRES 10 B 217 TYR GLY GLY MET GLU LEU PHE ARG ALA LEU GLY CYS SER SEQRES 11 B 217 GLU LEU ILE SER SER ILE PHE ASP PHE SER HIS SER LEU SEQRES 12 B 217 SER ALA LEU HIS PHE SER GLU ASP GLU ILE ALA LEU TYR SEQRES 13 B 217 THR ALA LEU VAL LEU ILE ASN ALA HIS ARG PRO GLY LEU SEQRES 14 B 217 GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN TYR ASN LEU SEQRES 15 B 217 GLU LEU ALA PHE HIS HIS HIS LEU CYS LYS THR HIS ARG SEQRES 16 B 217 GLN SER ILE LEU ALA LYS LEU PRO PRO LYS GLY LYS LEU SEQRES 17 B 217 ARG SER LEU CYS SER GLN HIS VAL GLU HET SO4 A 501 5 HET MPD A 502 8 HET HQ7 A 503 35 HET SO4 B 501 5 HET MPD B 502 8 HET HQ7 B 503 35 HETNAM SO4 SULFATE ION HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM HQ7 5-[(5R)-5-[(7-FLUORO-1,1-DIMETHYL-2,3-DIHYDRO-1H-INDEN- HETNAM 2 HQ7 5-YL)CARBAMOYL]-2-METHOXY-7,8-DIHYDRO-1,6- HETNAM 3 HQ7 NAPHTHYRIDIN-6(5H)-YL]-5-OXOPENTANOIC ACID FORMUL 3 SO4 2(O4 S 2-) FORMUL 4 MPD 2(C6 H14 O2) FORMUL 5 HQ7 2(C26 H30 F N3 O5) FORMUL 9 HOH *110(H2 O) HELIX 1 AA1 SER A 266 CYS A 285 1 20 HELIX 2 AA2 ARG A 288 ARG A 296 1 9 HELIX 3 AA3 SER A 301 LYS A 311 1 11 HELIX 4 AA4 SER A 312 ARG A 337 1 26 HELIX 5 AA5 CYS A 345 MET A 365 1 21 HELIX 6 AA6 GLY A 384 GLY A 392 5 9 HELIX 7 AA7 CYS A 393 ALA A 409 1 17 HELIX 8 AA8 SER A 413 ILE A 426 1 14 HELIX 9 AA9 GLU A 435 THR A 457 1 23 HELIX 10 AB1 ARG A 459 LEU A 466 5 8 HELIX 11 AB2 PRO A 468 GLU A 481 1 14 HELIX 12 AB3 SER B 266 THR B 284 1 19 HELIX 13 AB4 ARG B 288 GLN B 295 1 8 HELIX 14 AB5 ARG B 296 ASN B 298 5 3 HELIX 15 AB6 SER B 301 LYS B 311 1 11 HELIX 16 AB7 SER B 312 ARG B 337 1 26 HELIX 17 AB8 CYS B 345 CYS B 366 1 22 HELIX 18 AB9 GLY B 384 GLY B 392 5 9 HELIX 19 AC1 CYS B 393 LEU B 410 1 18 HELIX 20 AC2 SER B 413 ILE B 426 1 14 HELIX 21 AC3 GLU B 435 THR B 457 1 23 HELIX 22 AC4 SER B 461 LEU B 466 1 6 HELIX 23 AC5 PRO B 468 GLU B 481 1 14 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SHEET 1 AA2 3 TYR B 369 ASN B 370 0 SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370 SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378 SITE 1 AC1 3 HIS A 451 LEU A 463 HIS B 451 SITE 1 AC2 4 GLU A 290 GLU A 304 TYR A 308 LYS A 311 SITE 1 AC3 12 GLN A 286 CYS A 320 HIS A 323 LEU A 324 SITE 2 AC3 12 VAL A 361 ARG A 364 MET A 365 ALA A 368 SITE 3 AC3 12 PHE A 377 PHE A 378 GLU A 379 HOH A 603 SITE 1 AC4 1 LYS B 336 SITE 1 AC5 4 GLU B 290 GLU B 304 LYS B 311 ARG B 319 SITE 1 AC6 11 CYS B 320 HIS B 323 LEU B 324 VAL B 361 SITE 2 AC6 11 MET B 365 ALA B 368 PHE B 377 PHE B 378 SITE 3 AC6 11 GLU B 379 ILE B 400 HOH B 620 CRYST1 99.661 99.661 125.280 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010034 0.005793 0.000000 0.00000 SCALE2 0.000000 0.011586 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007982 0.00000